BMC Pulmonary Medicine (May 2019)

Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic

  • Adnan Azim,
  • Heena Mistry,
  • Anna Freeman,
  • Clair Barber,
  • Colin Newell,
  • Kerry Gove,
  • Yvette Thirlwall,
  • Matt Harvey,
  • Kimberley Bentley,
  • Deborah Knight,
  • Karen Long,
  • Frances Mitchell,
  • Yueqing Cheng,
  • Judit Varkonyi-Sepp,
  • Wolfgang Grabau,
  • Paddy Dennison,
  • Hans Michael Haitchi,
  • S. Hasan Arshad,
  • Ratko Djukanovic,
  • Tom Wilkinson,
  • Peter Howarth,
  • Ramesh J. Kurukulaaratchy

DOI
https://doi.org/10.1186/s12890-019-0862-2
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Asthma is now widely recognised to be a heterogeneous disease. The last two decades have seen the identification of a number of biological targets and development of various novel therapies. Despite this, asthma still represents a significant health and economic burden worldwide. Why some individuals should continue to suffer remains unclear. Methods The Wessex Asthma Cohort of Difficult Asthma (WATCH) is an ongoing ‘real-life’, prospective study of patients in the University Hospital Southampton Foundation Trust (UHSFT) Difficult Asthma service. Research data capture is aligned with the extensive clinical characterisation required of a commissioned National Health Service (NHS) Specialist Centre for Severe Asthma. Data acquisition includes detailed clinical, health and disease-related questionnaires, anthropometry, allergy and lung function testing, radiological imaging (in a small subset) and collection of biological samples (blood, urine and sputum). Prospective data are captured in parallel to clinical follow up appointments, with data entered into a bespoke database. Discussion The pragmatic ongoing nature of the WATCH study allows comprehensive assessment of the real world clinical spectrum seen in a Specialist Asthma Centre and allows a longitudinal perspective of deeply phenotyped patients. It is anticipated that the WATCH cohort would act as a vehicle for potential collaborative asthma studies and will build upon our understanding of mechanisms underlying difficult asthma.

Keywords